ALTAFLUOR
Live / Registered — Registered and renewed (as of 16 Sept 2025)
What this means for you
Registered since 17 May 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 May 2026).
Record
- Serial number
- 86813058
- Registration number
- 4960392
- Mark type
- Stylized text
- Filed
- 08 Nov 2015
- Published for opposition
- 01 Mar 2016
- Registered
- 17 May 2016
- Next maintenance due
- 17 May 2026
- Attorney of record
- Michael Sawaya
Goods and services
- Class 005 — Pharmaceuticals: Ocular pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical products for ophthalmological use
Owner
- Altaire Pharmaceuticals, Inc., Aquebogue, NY, US
- Altaire Pharmaceuticals, Inc., Aquebogue, NY, US
- Altaire Pharmaceuticals, Inc., Aquebogue, NY, US
Prosecution history
- 16 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Sept 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Sept 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 May 2025 — TEAS SECTION 8 & 9 RECEIVED
- 17 May 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 18 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 20 May 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 30 Apr 2022 — POST REGISTRATION ACTION MAILED - SEC. 8
- 30 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2021 — TEAS SECTION 8 RECEIVED
- 17 May 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 May 2016 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED